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Several side effects have been strongly associated with antiretroviral therapy in HIV patients. Among
them, the lipodystrophy syndrome which presents alterations in body shape with central adipose hypertrophy and
peripheral lipoatrophy, reported by patients as a visible marker identifying them as HIV patients. This manuscript
presents an analysis of current literature regarding the psychosocial aspects of HIV patients with lipodystrophy
associated with antiretroviral therapy. The results show that the alterations in body shape can be disturbing in terms
of psychosocial well being, affecting quality of life and increasing the stigma associated with the disease, with
consequent disturbances in social relations. This analysis provides a preliminary review of the psychosocial aspects
of lipodystrophy and further studies are needed for a better understanding of this complex syndrome, which could
provide new information to be used in nursing care for HIV patients affected by this problem.
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SÍNDROME DE LA LIPODISTROFIA ASOCIADO CON LA TERAPIA ANTIRETROVIRAL EN
PACIENTES CON VIH: CONSIDERACIONES PARA LOS ASPECTOS PSICOSOCIALES
Varios efectos secundarios han sido fuertemente asociados con la terapia antiretroviral en pacientes con HIV.
Entre ellos, el síndrome de la lipodistrofia se presenta con alteraciones en la forma del cuerpo con hipertrofia adiposa
central y lipoatrofia periférica, las cuales son reportadas por pacientes como marcas visibles que los identifica como
pacientes con VIH. En este manuscrito, presentamos un análisis de literatura actual con respecto a los aspectos psicosociales
de pacientes con VIH presentándose con lipodistrofia asociado con la terapia antiretroviral. Los resultados demuestran que
las alteraciones de la forma del cuerpo pueden ser inquietantes en lo que se refiere al bienestar psicosocial, afectando la
calidad de vida y aumentando el estigma asociado con la enfermedad, con las consiguientes dificultades en las relaciones
sociales. Este análisis provee un repaso preliminar de los aspectos psicosociales de la lipodistrofia; sin embargo, otros
estudios son necesarios para entender mejor este complejo síndrome, proveyendo nueva información para ser utilizada
en el cuidado de enfermería para pacientes con VIH que están afectados por este problema.
DESCRIPTORES: VIH; síndrome de inmunodeficiencia adquirida; lipodistrofia; enfermería
SINDROME DA LIPODISTROFIA ASSOCIADA COM A TERAPIA ANTI-RETROVIRAL EM
PORTADORES DO HIV: CONSIDERAÇÕES PARA OS ASPECTOS PSICOSSOCIAIS
Diversos efeitos colaterais têm sido associados à terapia anti-retroviral em portadores da infecção pelo HIV,
dentre esses, a síndrome da lipodistrofia apresentando hiperlipidemia e alterações na forma do corpo, com hipertrofia
adiposa central e lipoatrofia periférica, relatada pelos pacientes como um visível marcador para a identificação de
portadores da infecção pelo HIV. Este estudo consiste em análise da produção científica sobre aspectos psicossociais
em portadores da infecção pelo HIV que apresentam lipodistrofia associada à utilização da terapia anti-retroviral. Os
resultados mostram que alterações corporais podem ser suficientemente perturbadoras para o bem-estar psicossocial,
afetando a qualidade de vida e aumentando o estigma da doença, ocasionando perturbações nas relações sociais.
Esta revisão possibilita uma análise preliminar dos aspectos psicossocias da lipodistrofia; entretanto, outros estudos
são necessários para o melhor entendimento desta complexa síndrome, trazendo novas informações a serem utilizadas
no cuidado de enfermagem a portadores da infecção pelo HIV afetados por este problema.
DESCRITORES: HIV; síndrome de imunodeficiência adquirida; lipodistrofia; enfermagem
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INTRODUCTION
Lipodystrophy, characterized by increased
serum levels of cholesterol and triglycerides,
increased glycemia associated with insulin resistance,
and changes in body fat distribution, is a syndrome
associated with antiretroviral therapy(1). Symptoms
of lipodystrophy include adipose tissue hypertrophy
with central fat distribution, fat accumulation in the
abdomen, chest and viscera, emergence of a cervical
curvature called “buffalo hump”, and loss of adipose
tissue in the face, buttocks and upper and lower
limbs(2). Although it was first associated with the use
of protease inhibitors, this syndrome has also been
found among patients using reverse transcriptase
inhibitors(3). The pathogenesis of this syndrome
remains largely unknown, although the effects of
antiretroviral treatment on the onset of lipodystrophy
have been described(1). In addition, it has been
reported that poor compliance with antiretroviral
therapy can be strongly associated with an increased
risk of lipodystrophy occurrence(4).
Changes in body shape can be extremely
disturbing in terms of psychological welfare affecting
the quality of life and enhancing the stigma of the
disease(3,5). Patients have reported lipodystrophy as a
visible marker that identifies HIV status, and is
perceived as “the new face of AIDS” or “the Kaposi’s
sarcoma of the 21st century”(6). In addition,
lipodystrophy causes problems in personal and family
relations, which in some cases can trigger disturbances
in social relations, often leading to total patient isolation.
Perhaps most significantly, some patients stop taking
their antiretroviral regimen in order to avoid the
adverse psychosocial effects of fat wasting(5-7).
The present literature review investigated the
associations between the occurrence of lipodystrophy
and the different parts of the body affected, the
psychosocial impact of the disease, and the possible
implications of lipodystrophy on the adherence to
antiretroviral therapy. The objective of this review
was to ultimately be able to offer information that
may assist in developing and implementing future
nursing interventions for AIDS patients.
METHODS
The increased emphasis on evidence-based
health care requires nurses to have access to reviews
that analyze and summarize the current state of
research in their areas of practice. Practitioners must
be able to efficiently locate, critically appraise and
appropriately apply the best available evidence in their
practice settings. The identification and retrieval of
relevant publications in a systematic, comprehensive
and reproducible way is the initial phase in the
literature review process.
Our search strategy included a computerized
search of electronic databases. Among the biomedical
bibliographic databases, Medline, Lilacs and CINAHL
are the largest and most widely used in the world(8).
Therefore, this review included a review of the literature
indexed in Medline (National Library of Medicine), Lilacs
(Latin American and Caribbean Literature in Health
Sciences) and CINAHL (Cumulative Index to Nursing
& Allied Health Literature) through the Internet database
updated in December 2004. The following key words
were utilized for the review: HIV, AIDS, lipodystrophy,
self-esteem, self-image, psychosocial impact, and
nursing. The outcomes of the electronic searches were
evaluated on the basis of their sensitivity and
specificity. “Sensitivity” is the ability of a search to
retrieve relevant articles. “Specificity” is the ability of
the search to exclude irrelevant articles. The following
criteria were used to select papers:
Articles dealing with:
1) the psychosocial aspects of HIV patients with bodily
changes;
2) the impact of lipodystrophy on the self-esteem and
self-image of affected individuals;
3) published in indexed journals from 1998 to 2004.
RESULTS AND DISCUSSION
Limited research has been conducted on body
image in people infected with HIV. This review found
ten articles dealing with the topic area in the Medline
database. Eight studies were published in the following
medical journals: “HIV Medicine”, “AIDS Patient Care
STDS”, “AIDS Read”, “International Journal of STD &
AIDS”, “Sexually Transmitted Infection”, “Dermatologic
Surgery”, and “Clinical Infectious Disease”. When the
search terms “nursing”, “HIV” and “lipodystrophy”
were entered, two articles published in journals related
to nursing were located in: “Applied Nursing Research”
and the “Journal of the Association of Nurses in AIDS
Care”. No pertinent publications were found in the
Lilacs or CINAHL databases.
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The search revealed that the literature on this
topic was concentrated between 2000 and 2004,
reflecting the recent worldwide emergence of the
syndrome. Unfortunately there was a shortage of
nursing investigations regarding lipodystrophy,
although the most frequently reported psychological
and social effects were relevant to nursing practice.
These effects included the erosion of body image and
self esteem, anxiety, problems in social and sexual
relations, and propensity toward demoralization and
depression(5-6,9-10). An interesting finding is that in Brazil,
a country known throughout the world for its policy of
universal distribution of antiretroviral medications,
nurses have not published on this topic. This supports
the necessity for this type of investigation.
Lipodystrophy is diagnosed subjectively,
generally by the presence of lipoatrophy and/or fat
accumulation on physical examination and/or patient
report. In this review, three of the articles presented
different definitions of lipodystrophy: 1) “poorly
understood condition associated with antiretroviral
therapy in HIV infection whose symptoms may include
a combination of central fat accumulation, peripheral
fat depletion and metabolic disorders”(5); 2) “growing
problem in human immunodeficiency virus-positive
patients treated with highly active antiretroviral
therapy”(7); and 3) “unexplained trunk fat accumulation
and/or fat loss in the face or extremities”(11). These
different definitions suggest that lipodystrophy is still
a syndrome that has not been fully clarified and
defined, needing objective criteria by which to
diagnose lipodystrophy. Consensus at the 1st
International Workshop on Adverse Drug Reactions
and Lipodystrophy in HIV was that the presence of at
least one patient-reported physical change confirmed
on physical examination may be useful for diagnosis,
but it was agreed that this consensus was opinion
based rather than evidence based(12). Despite the fact
that in Brazil 140,000 AIDS patients use antiretroviral
treatment(13) and that between 50 to 80% of AIDS
patients develop lipodystrophy(2), this review did not
reveal any Brazilian studies discussing the definition
of lipodystrophy.
In recent studies, lipodystrophy was observed
in 34%(11) and 37.7% of German patients(7), and 56%
of Spanish patients(9). Investigations that analyzed the
onset of lipodystrophy according to the symptoms,
observed an increase in abdominal girth in 32 to 60%
of individuals, breast enlargement in 20%, facial
lipoatrophy in 58%, loss of peripheral fat in 33 to
50%, and mixed manifestations in 8 to 86 % of
patients(9,14-15). According to the literature surveyed,
the pathogeny of lipodystrophy continues to be largely
unknown, although several risk factors for its
occurrence have been described, including long-term
HIV infection, prolonged use of protease inhibitors(14)
and a CD4 count below 200 cells/mL(11).
Several psychosocial alterations related to
lipodystrophy were highlighted in the review. These
included dissatisfaction with body image(5-6), mood
alterations demonstrated by anxiety and
unhappiness(15), problems in sexual relations(5),
reduction in self-esteem, and depression(5-6).
Furthermore, quality of life and different responses
to weight change among women and men were
reported. CORLESS and colleagues(16), suggest that
body image was significantly related to reduction of
overall health, physical functioning and mental health
in men, however no difference in quality of life was
found for women
In relation to the affected region, facial
lipodystrophy is noticed more often than other body
changes. Therefore, patients with facial changes are
more worried about stigmatization. Facial lipoatrophy
was cited as an important stigmatizing factor for HIV
patients, rendering them more vulnerable to the
identification of seropositivity and consequently leading
to decreased self-esteem and socialization(9-10).
Alterations in body image faced by these
patients have repercussions on affective and emotional
health(17). Thus, taking into consideration the benefits
of antiretroviral therapy, several patients feel that the
iatrogenic costs are so difficult to tolerate that they
end up by abandoning treatment(17). This behavior can
be understood if we consider not only the
stigmatization currently associated with HIV/AIDS, but
also the pressure for a “perfect body” currently
emphasized by society.
The “contamination” of body image currently
associated with lipodystrophy has been documented;
however, the mechanisms underlying the visible
disfiguring and stigmatizing morphological changes
are still unknown(10,15,17). In addition, BLANCH and
colleagues(9) found that decreased sexual enjoyment
and activity were observed after the development of
lipodystrophy; however, there were no change in the
frequency of condom use. Patients also felt less
physically well  and were less confident in their
relationships during their experience of
lipodystrophy(9).
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Regarding compliance to antiretroviral
therapy, one study found that some patients intended
to interrupt or abandon treatment as a result of body
changes(15). According to the literature, preoccupation
and anxiety about the future and the possibility of
occurrence of lipodystrophy, with its metabolic and
morphologic complications, are frequent. However,
patients who experienced complications of HIV
infection and were near death considered lipodystrophy
as a manageable price to be paid in exchange for
longevity(6). Inadequate adherence to treatment is a
major, if not the most important, factor associated
with treatment failure. Insufficient plasma levels of
the medications and partial suppression of viral
replication are ideal conditions for the development
of viral resistance, with the possible emergence of
drug-resistant viral strains(5).
CONCLUSION
Lipodystrophy syndrome is a significant side
effect of antiretroviral treatment, not only due to its
increased prevalence, but also due to its interference
with treatment. This is due to the metabolic and
morphologic alterations that contribute to the reduction
in adherence to treatment and with the reduced quality
of life in individuals affected by the syndrome.
The present review revealed a scarcity of
studies dealing with the lipodystrophy psychosocial
outcomes. The repercussions of this syndrome on the
well being of HIV patients, frequently neglected despite
the large number of affected patients, were highlighted.
Additionally, the review highlighted many issues that
are relevant for nurses in the care and treatment of
AIDS patients. Understanding the impact of this
syndrome, including the clinical and psychological
implications, is essential for the planning of nursing care
for AIDS patients. Thus, caring for people with AIDS
calls upon a range of physical, psychological, social,
and spiritual interventions that, in the absence of a cure,
can make a palpable difference for patients(18).
Health care providers, researchers, and
policy makers are inundated with unmanageable
amounts of information. They require literature
reviews to efficiently integrate existing information
and provide data for rational decision-making.
Although this bibliographic review permitted an
important summary of the psychosocial aspects of
lipodystrophy due to antiretroviral therapy, further
studies are needed for a better understanding of this
complex syndrome, providing new information to be
used in nursing care of HIV patients affected by this
problem.
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